Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases
Clinical trial NCT06250777 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06250777
- Sponsor
- Yonsei University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-11
- Primary completion
- 2026-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.